For sixty years, Americans paid more for the same pills than anyone else on earth.
Politicians in Washington, DC promised to fix it every election cycle and delivered nothing.
But Donald Trump just made nine more pharmaceutical giants an offer they couldn't refuse.
The Win Washington Told You Was Impossible
Nine companies – Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB – signed the Most Favored Nation deals with Trump on Monday.
Every state Medicaid program now gets access to the lowest prices these companies charge anywhere in the world.
That covers hemophilia. Parkinson's, macular degeneration, glaucoma, liver disease, and cancers of every kind.
https://twitter.com/HHSResponse/status/2094507002063904850?s=20
The White House projects billions in savings, and those nine companies committed to a collective $19.6 billion in U.S. manufacturing investment.
"Nine new pharmaceutical companies are committing to deliver their lowest drug prices for American patients," Trump said from the Oval Office.
That's 26 total MFN deals since last fall.
Nearly 90 percent of the branded drug market is now under agreement.
What Biden, Obama, and Clinton All Told You Was Too Hard
For decades, drug company lobbyists owned Washington.
Clinton's FDA rewrote the rules in 1997 to let pharmaceutical companies advertise directly to patients – turning your television into a pill commercial and your doctor into a salesman.
When Trump first tried this in his first term, Congress blocked him.
The Biden White House reversed his MFN initiatives entirely – then bragged about negotiating 10 drugs through the Inflation Reduction Act over four years while drug prices kept climbing.
Obama's administration rejected calls to use "march-in rights" that would have lowered prices on taxpayer-funded drugs – and then Biden appointed the same official who had demanded those rights be used, who promptly refused to use them once he had the job.
The result: Americans paid roughly three times more for the same branded drugs as patients in other wealthy nations, while Big Pharma posted profit margins above 20 percent on research often subsidized by taxpayers.
Trump came back and changed the math.
The Scoreboard Doesn't Lie
Prescription drug prices are down 3.9 percent since Trump took office.
They have dropped every single month this year.
The Bureau of Labor Statistics confirmed a 3.1 percent year-over-year decline in July – the steepest annual drop since 1963.
TrumpRx has already delivered $700 million in direct patient savings.
GLP-1 weight-loss and diabetes drugs – the ones hitting over $1,000 a month before – now start at $149.
Insulin, inhalers, fertility drugs, and cholesterol treatments have fallen 50 to 90 percent.
The VA locked in more than $10 billion in pharmaceutical savings this fiscal year alone.
Rep. Jimmy Patronis put it plainly: "Without even twisting an arm, without trying to pass a new bill, he brought all these players together with TrumpRX to lower the cost of prescription drugs, and he continues to do that because this guy understands leverage."
Why This Is Bigger Than a Policy Win
Big Pharma spent a generation buying Washington – both parties – to maintain a pricing structure that made Americans subsidize cheaper drugs for every other wealthy nation on the planet.
Every president who promised to fix it ran into the same wall.
Trump didn't try to climb the wall.
He walked around it by using executive leverage, tariff pressure, and the bully pulpit to bring nearly 90 percent of the branded drug market to the table voluntarily – no new law required, no Senate vote, no filibuster.
And as a bonus, these companies are now stocking America's Strategic Active Pharmaceutical Ingredients Reserve.
UCB is contributing 163 tons of the anticonvulsant levetiracetam.
Teva is contributing metronidazole and amlodipine.
Sun Pharma is donating antibiotics.
The pharmaceutical supply chain that Democrats left dangerously dependent on China is being rebuilt at the same time drug prices are being slashed.
That's not a talking point.
That's sixty years of failure finally getting fixed.
Sources:
- Nick Gilbertson, "Trump Reaches Deals with Nine More Pharmaceutical Companies to Slash Drug Prices," Breitbart, August 31, 2026.
- "Fact Sheet: President Donald J. Trump Announces Deal with Nine Additional Pharmaceutical Manufacturers to Lower Drug Prices for Americans," White House, August 31, 2026.
- "President Trump Delivers Largest Prescription Drug Price Drop in Over 60 Years," White House, August 17, 2026.
- "Americans Stop Paying the World's Pharmacy Tab as Prices Fall Hardest Since 1963," Just The News, August 2026.
- "Lowering Drug Prices by Once Again Putting Americans First," White House Executive Order, April 2025.